Adenomyosis-associated infertility: an update of the immunological perspective
Reproductive BioMedicine Online · 2025-05 · 50 (5) · 104703
DOI: 10.1016/j.rbmo.2024.104703 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Reproductive BioMedicine Online, 2025-05. Verfasst von Ying Cao und 11 weiteren Autor:innen. Beteiligte Einrichtung: Reproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Adenomyosis, Infertility, Female. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 228 Literaturangaben. Gefördert von: Natural Science Foundation of Guangdong Province, National Natural Science Foundation of China, Renmin Hospital of Wuhan University.
Abstract (Originalsprache)
Adenomyosis is characterized by the invasion of endometrial glands and stroma into the myometrium. Its clinical manifestations often include dysmenorrhoea, excessive menstrual bleeding and infertility. Reduced pregnancy and live birth rates and an increased miscarriage rate are observed in women with adenomyosis. This review summarizes relevant advances and presents the underlying mechanisms of adenomyosis-associated infertility from an immunological perspective. Individuals with adenomyosis exhibit imbalances in immune cell subpopulations and the endocrine hormone-immunomodulatory axis. These immunological alterations may be key contributors to, or at least accomplices in, impaired endometrial receptivity. In addition, adenomyosis often occurs in association with endometriosis, uterine leiomyoma or endometrial polyps, which are pathogenetically relevant; their similarities and differences are discussed from an immunological perspective. The clinical diagnostic criteria of adenomyosis are not perfect, and the pathogenesis remains to be fully explored. Therefore screening for effective targets for early diagnosis and treatment at the cellular and molecular levels from the immunological point of view holds great potential, which will be of great importance in preventing this disease and improving women's reproductive health.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Reproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China.
- Shenzhen Key Laboratory of Reproductive Immunology for Peri-implantation, Shenzhen Zhongshan Institute for Reproductive Medicine and Genetics, Shenzhen Zhongshan Obstetrics and Gynecology Hospital (formerly Shenzhen Zho…
- Reproductive Medicine Center, Renmin Hospital of Wuhan University, Wuhan, Hubei, China. Electronic address: reproductive@whu.edu.cn.
Förderung
- Natural Science Foundation of Guangdong Province
- National Natural Science Foundation of China
- Renmin Hospital of Wuhan University
- Science, Technology and Innovation Commission of Shenzhen Municipality
Zitieren
APA
Cao, Y., Yang, D., Cai, S., Yang, L., Yu, S., Geng, Q., Mo, M., Li, W., Wei, Y., Li, Y., Yin, T., & Diao, L. (2025). Adenomyosis-associated infertility: an update of the immunological perspective. Reproductive BioMedicine Online, 50(5), 104703. https://doi.org/10.1016/j.rbmo.2024.104703
Vancouver
Cao Y, Yang D, Cai S, Yang L, Yu S, Geng Q, et al. Adenomyosis-associated infertility: an update of the immunological perspective. Reproductive BioMedicine Online. 2025;50(5):104703. doi:10.1016/j.rbmo.2024.104703
BibTeX
@article{Cao2025,
author = {Cao, Ying and Yang, Dongyong and Cai, Songchen and Yang, Lingtao and Yu, Shuyi and Geng, Qiang and Mo, Meilan and Li, Wenzhu and Wei, Yiqiu and Li, Yuye and Yin, Tailang and Diao, Lianghui},
title = {Adenomyosis-associated infertility: an update of the immunological perspective},
journal = {Reproductive BioMedicine Online},
year = {2025},
volume = {50},
number = {5},
pages = {104703},
doi = {10.1016/j.rbmo.2024.104703}
}
EUVIMED